Stable glioma incidence and increased patient survival over the past two decades in Norway: a nationwide registry-based cohort study.

ABSTRACT:

Background

Surveillance of incidence and survival of central nervous system tumors is essential to monitor disease burden and epidemiological changes, and to allocate health care resources. Here, we describe glioma incidence and survival trends by histopathology group, age, and sex in the Norwegian population.

Material and methods

We included patients with a histologically verified glioma reported to the Cancer Registry of Norway from 2002 to 2021 (N = 7,048). Population size and expected mortality were obtained from Statistics Norway. Cases were followed from diagnosis until death, emigration, or 31 December 2022, whichever came first. We calculated age-standardized incidence rates (ASIR) per 100,000 person-years and age-standardized relative survival (RS).  Results: The AS

SUBMITTER: Skaga E 

PROVIDER: S-EPMC11332456 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature